Maravai LifeSciences (MRVI) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $53.63M.

In the most recent quarter (Q4), Maravai LifeSciences reported EPS of $-0.04, beating estimates of $-0.08 by 0.50%. Revenue came in at $49.87M, exceeding the estimate of $49.14M by 0.01%.

Over the last 4 quarters, Maravai LifeSciences has averaged an EPS surprise of 0.16% and a revenue surprise of 0.06%.